Trial Outcomes & Findings for Interest in Electronic Applications for Patients With Glaucoma (NCT NCT02659709)
NCT ID: NCT02659709
Last Updated: 2019-08-05
Results Overview
Responses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
COMPLETED
50 participants
1 hour
2019-08-05
Participant Flow
Glaucoma patients and Caregivers were recruited from the Glaucoma Service at Wills Eye Hospital, Philadelphia, PA, USA.
Participant milestones
| Measure |
Glaucoma Patients and Caregivers
Glaucoma patients and caregivers will test a glaucoma smartphone application (app) on smart phones or tablets then complete 20 item questionnaire providing demographic information, effectiveness and ease of use with the application designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.
|
|---|---|
|
Overall Study
STARTED
|
50
|
|
Overall Study
COMPLETED
|
50
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Interest in Electronic Applications for Patients With Glaucoma
Baseline characteristics by cohort
| Measure |
Glaucoma Patients and Caregivers
n=50 Participants
50 Glaucoma patients and/or caregivers will test a glaucoma application (app) on smart phones or tablets then complete a 20 item questionnaire providing demographic information, effectiveness and ease of use with the application designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.
|
|---|---|
|
Age, Categorical
<=18 years
|
1 Participants
n=99 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
32 Participants
n=99 Participants
|
|
Age, Categorical
>=65 years
|
17 Participants
n=99 Participants
|
|
Sex: Female, Male
Female
|
32 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
18 Participants
n=99 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Black or African American
|
9 Participants
n=99 Participants
|
|
Race (NIH/OMB)
White
|
33 Participants
n=99 Participants
|
|
Race (NIH/OMB)
More than one race
|
3 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
3 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
50 participants
n=99 Participants
|
PRIMARY outcome
Timeframe: 1 hourPopulation: Participants responding Yes to owning a smartphone or tablet.
Responses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
Outcome measures
| Measure |
Glaucoma Smartphone Application
n=50 Participants
Glaucoma patients and/or caregivers answered a Questionnaire on availability to Smartphone or Tablet Usage and accessing social media. Questionnaire includes 20 items regarding demographic information, effectiveness of social media and compliance with glaucoma medications.
From this information, Smartphone Application will be designed to educate glaucoma patients about the disease, testing, and treatments and also include reminders for taking medications.
|
|---|---|
|
Patients Owning Smartphone/Tablet Technology
|
34 Participants
|
PRIMARY outcome
Timeframe: 1 hourPopulation: Participants responding Yes to anyone in the house owning a smartphone or tablet.
Responses collected from participants about their personal access, through other members in the home, to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
Outcome measures
| Measure |
Glaucoma Smartphone Application
n=50 Participants
Glaucoma patients and/or caregivers answered a Questionnaire on availability to Smartphone or Tablet Usage and accessing social media. Questionnaire includes 20 items regarding demographic information, effectiveness of social media and compliance with glaucoma medications.
From this information, Smartphone Application will be designed to educate glaucoma patients about the disease, testing, and treatments and also include reminders for taking medications.
|
|---|---|
|
Patients Having Access to Social Media Via Smartphone or Tablet in the Home
|
39 Participants
|
SECONDARY outcome
Timeframe: 1 hourPopulation: Participants responding Yes using their glaucoma eye drops as prescribed.
Responses collected from participants about compliance to using their glaucoma drops as prescribed obtained by completing a 20 item questionnaire.
Outcome measures
| Measure |
Glaucoma Smartphone Application
n=50 Participants
Glaucoma patients and/or caregivers answered a Questionnaire on availability to Smartphone or Tablet Usage and accessing social media. Questionnaire includes 20 items regarding demographic information, effectiveness of social media and compliance with glaucoma medications.
From this information, Smartphone Application will be designed to educate glaucoma patients about the disease, testing, and treatments and also include reminders for taking medications.
|
|---|---|
|
Glaucoma Medication Compliance
|
25 Participants
|
SECONDARY outcome
Timeframe: 1 hourPopulation: Participants responding Yes to using their glaucoma eye drops as prescribed without reminders.
Responses collected from participants about use of medication reminders for their glaucoma drops obtained by completing a 20 item questionnaire.
Outcome measures
| Measure |
Glaucoma Smartphone Application
n=50 Participants
Glaucoma patients and/or caregivers answered a Questionnaire on availability to Smartphone or Tablet Usage and accessing social media. Questionnaire includes 20 items regarding demographic information, effectiveness of social media and compliance with glaucoma medications.
From this information, Smartphone Application will be designed to educate glaucoma patients about the disease, testing, and treatments and also include reminders for taking medications.
|
|---|---|
|
Use of Medication Reminder
|
28 Participants
|
Adverse Events
Glaucoma Smartphone Application
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Jonathan S. Myers
Wills Eye Hospital, Glaucoma Service
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place